Go to ValuEngine.com

May 28, 2015

ATTENTION Advanced Investors and Finance Professionals:
If you are reading this you should download ValuEngine Institutional Software to see how VE’s powerful quantitative tools can increase your productivity and effectiveness.

VALUATION WATCH: Overvalued stocks now make up 61.66% of our stocks assigned a valuation and 25.5% of those equities are calculated to be overvalued by 20% or more.  Fifteen sectors are calculated to be overvalued--with six at or near double digits.


--Not Such a Loser After All

ValuEngine Small Cap Pick Affimed Therapeutics Up More than 25%

Affimed Therapeutics B.V. (AFMD) is a clinical-stage biopharmaceutical company. It is focused on discovering and developing cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology. The Company's TandAbs has the ability to bring NK-cells or T-cells into proximity and trigger a signal cascade that leads to the destruction of cancer cells. Its product pipeline includes AFM13, AFM11 and AFM21. Affimed Therapeutics B.V. is headquartered in Heidelberg, Germany.

The company reported better than expected earnings last week and has seen a nice jump in share price as a result. They cut in half the expected loss predicted by analysts and reported ($0.07)/share--versus the expected ($0.14)/share. The stock is a position in our VE Small Cap Stock Strategy portfolio for the month and is currently leading the way with a gain in excess of 25%.

VALUENGINE RECOMMENDATION: ValuEngine continues its STRONG BUY recommendation on Affimed Therapeutics for 2015-05-27. Based on the information we have gathered and our resulting research, we feel that Affimed Therapeutics has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE P/E Ratio and Sharpe Ratio.




As a bonus to our Newsletter readers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Read our Complete Detailed Valuation Report on Affimed Therapeutics HERE.

Below is today's data on AFMD:


ValuEngine Forecast
 
Target
Price*
Expected
Return
1-Month
 10.20 1.11%
3-Month
 10.40 3.10%
6-Month
 10.72 6.23%
1-Year
 11.44 13.34%
2-Year
 10.69 5.90%
3-Year
 10.14 0.48%

Valuation & Rankings
Valuation
n/a
Valuation Rank(?)
 n/a
1-M Forecast Return
1.11%
1-M Forecast Return Rank
 99
12-M Return
n/a
Momentum Rank(?)
 n/a
Sharpe Ratio
0.42
Sharpe Ratio Rank(?)
 72
5-Y Avg Annual Return
38.80%
5-Y Avg Annual Rtn Rank
 97
Volatility
91.54%
Volatility Rank(?)
 11
Expected EPS Growth
-136.74%
EPS Growth Rank(?)
 3
Market Cap (billions)
0.24
Size Rank
 46
Trailing P/E Ratio
4.33
Trailing P/E Rank(?)
 100
Forward P/E Ratio
n/a
Forward P/E Ratio Rank
 n/a
PEG Ratio
n/a
PEG Ratio Rank
 n/a
Price/Sales
n/a
Price/Sales Rank(?)
 n/a
Market/Book
7.01
Market/Book Rank(?)
 19
Beta
2.59
Beta Rank
 6
Alpha
n/a
Alpha Rank
 n/a

Want To Know More About Our ValuEngine View Newsletter?

Looking for a monthly portfolio of stock picks which are objective and based on cutting-edge academic theory and Wall St.practice? Then subscribe to The ValuEngine View Newsletter.The ValuEngine View Portfolio is based on our highly-refined and tested ValuEngine Portfolio Strategies along with our proprietary quant-based composite scoring system. The ValuEngine View Newsletter is the product of sophisticated stock valuation and forecast models first developed by Yale Professor of Finance Zhiwu Chen.

The ValuEngine View Newsletter is the product of a sophisticated stock valuation model that was first developed by ValuEngine's academic research team. It utilizes a three factor approach: fundamental variables such as a company's trailing 12-month Earnings-Per-Share (EPS), the analyst consensus estimate of the company's future 12-month EPS, and the 30-year Treasury yield are all used to create a more accurate reflection of a company's fair value. A total of eleven additional firm specific variables are also used. In addition, the portoflio uses top picks from our Forecast Model. In essence, the portfolio is constructed with the best picks from our main propiretary models

Each month you will receive an electronic copy of our newsletter highlighting 15 potential long positions along with five alternate picks. Our investment strategies focus on dozens of fundamental and technical factors for over 8000 individual stocks, synthesize the data, and then come up with a portfolio. Each newsletter portfolio focuses on maximum potential returns so there are no diversity requirements. Each portfolio pick includes critical ValuEngine valuation and forecast data. These 20 total picks represent the most up-to-date equity assessments of our proprietary models.

Please click HERE to subscribe. You may download a sample copy HERE. After your subscription is approved, you will immediately receive access to download the current issue of newsletter as well as the previous issues, which are all available as PDF files. Each month when the latest issue of the newsletter is released, we will send you an email, informing you to download it from the site. The newsletter is released near the middle of each month.

 

  VE View vs. S&P 500 Index Past Five Years
VE View
S&P 500
Ann Return
 24.78% 14.56%
Ann Volatility
 22.28% 12.35%
Sharpe Ratio
 1.11 1.18
Sortino Ratio
 1.88 1.53
Max Drawdown
 -34.94% -11.14%

  The ValuEngine View Newsletter is derived from the ValuEngine Aggressive and Diversified Growth BenchmarkPortfolio Strategies. These strategies are the product of ValuEngine's academic research team and combine cutting-edge financial analysis and portfolio construction techniques with real-world Wall St. know how. 

CLICK HERE to Subscribe to the ValuEngine View

The ValuEngine View Newsletter portfolio has 15 primary stock picks and five alternates and is re-balanced once each month. The ValuEngine View Newsletter is published near the middle of each calendar month. An equal amount of capital is allocated to each stock. The monthly returns are calculated from the closing prices on date of publication. The performance calculation does not include any transaction costs.

 

 

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued
38.34%
Stocks Overvalued
61.66%
Stocks Undervalued by 20%
12.93%
Stocks Overvalued by 20%
25.5%

ValuEngine Sector Overview

Sector
Change
MTD
YTD
Valuation
Last 12-MReturn
P/E Ratio
0.92%
2.50%
12.85%
21.69% overvalued
14.09%
31.53
0.13%
0.73%
5.79%
19.93% overvalued
-3.08%
20.84
0.91%
3.10%
7.15%
14.77% overvalued
6.78%
31.61
0.61%
1.13%
4.32%
12.65% overvalued
2.67%
24.99
0.36%
1.95%
7.73%
9.92% overvalued
1.57%
28.09
0.38%
1.13%
1.71%
9.57% overvalued
6.97%
26.43
0.73%
0.57%
6.93%
8.64% overvalued
5.74%
26.20
0.29%
0.63%
4.53%
8.02% overvalued
1.36%
22.56
-0.27%
-5.49%
1.97%
6.75% overvalued
-32.07%
25.46
0.43%
0.33%
3.84%
5.42% overvalued
3.65%
17.79
0.77%
1.90%
3.26%
5.39% overvalued
0.87%
24.65
0.96%
-0.25%
1.83%
4.83% overvalued
-2.32%
21.37
1.00%
1.34%
6.34%
4.76% overvalued
-4.06%
16.68
0.60%
1.21%
3.29%
2.69% overvalued
-4.25%
20.04
0.73%
-0.23%
2.25%
1.77% overvalued
3.26%
19.76
0.17%
-0.20%
2.67%
1.77% undervalued
-15.10%
24.40

 

 

 

ValuEngine.com Products and Services

 

 

With the ValuEngine Forecast 16 Market Neutral Strategy Portfolio Newsletter, you can run your own portfolio like a hedge fund to manage risk and profit in any market environment.
With ValuEngine.com's Premium Website Membership you get forecasts, valuations, and recommendations on more than 7,000 stocks updated every trading day! 
NO OBLIGATION, 14-DAY FREE TRIAL!

 
 
 
Close this window
ValuEngine.com - Rational advice, smarter investing.